Latest Darwin Global Management, Ltd. Stock Portfolio
$751Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Darwin Global Management, Ltd. and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Darwin Global Management, Ltd. reported an equity portfolio of $751.2 Millions as of 31 Mar, 2024.
The top stock holdings of Darwin Global Management, Ltd. are PCVX, NUVL, KROS. The fund has invested 25% of it's portfolio in VAXCYTE INC and 14.4% of portfolio in NUVALENT INC.
The fund managers got completely rid off AMBRX BIOPHARMA INC (AMAM), TG THERAPEUTICS INC (TGTX) and MOONLAKE IMMUNOTHERAPEUTICS (MLTX) stocks. Darwin Global Management, Ltd. opened new stock positions in BIOHAVEN LTD, ALPINE IMMUNE SCIENCES INC (ALPN) and BEAM THERAPEUTICS INC (BEAM). The fund showed a lot of confidence in some stocks as they added substantially to NUVALENT INC (NUVL), VAXCYTE INC (PCVX) and KEROS THERAPEUTICS INC (KROS).
The top stock holdings of Darwin Global Management, Ltd. are PCVX, NUVL, KROS. The fund has invested 25% of it's portfolio in VAXCYTE INC and 14.4% of portfolio in NUVALENT INC.
The fund managers got completely rid off AMBRX BIOPHARMA INC (AMAM), TG THERAPEUTICS INC (TGTX) and MOONLAKE IMMUNOTHERAPEUTICS (MLTX) stocks. Darwin Global Management, Ltd. opened new stock positions in BIOHAVEN LTD, ALPINE IMMUNE SCIENCES INC (ALPN) and BEAM THERAPEUTICS INC (BEAM). The fund showed a lot of confidence in some stocks as they added substantially to NUVALENT INC (NUVL), VAXCYTE INC (PCVX) and KEROS THERAPEUTICS INC (KROS).
New Buys
| Ticker | $ Bought |
|---|---|
| BIOHAVEN LTD | 80,775,700 |
| ALPINE IMMUNE SCIENCES INC | 78,567,100 |
| BEAM THERAPEUTICS INC | 70,031,500 |
| APOGEE THERAPEUTICS INC | 55,299,600 |
| XENCOR INC | 24,556,600 |
| SPYRE THERAPEUTICS INC | 17,948,500 |
| ELEVATION ONCOLOGY INC | 11,967,900 |
| TOURMALINE BIO INC | 10,648,500 |
New stocks bought by Darwin Global Management, Ltd.
Additions
| Ticker | % Inc. |
|---|---|
| NUVALENT INC | 2,390 |
| VAXCYTE INC | 374 |
| KEROS THERAPEUTICS INC | 35.41 |
Additions to existing portfolio by Darwin Global Management, Ltd.
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| AMBRX BIOPHARMA INC | -237,646,000 |
| TG THERAPEUTICS INC | -69,115,900 |
| MOONLAKE IMMUNOTHERAPEUTICS | -62,762,700 |
| CYTOKINETICS INC | -50,094,000 |
| SPRINGWORKS THERAPEUTICS INC | -7,034,790 |
Darwin Global Management, Ltd. got rid off the above stocks
Current Stock Holdings of Darwin Global Management, Ltd.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AGLE | SPYRE THERAPEUTICS INC | 2.39 | 473,200 | 17,948,500 | NEW | ||
| ALPN | ALPINE IMMUNE SCIENCES INC | 10.46 | 1,982,020 | 78,567,100 | NEW | ||
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BEAM | BEAM THERAPEUTICS INC | 9.32 | 2,119,600 | 70,031,500 | NEW | ||
| CYTK | CYTOKINETICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ELEV | ELEVATION ONCOLOGY INC | 1.59 | 2,332,930 | 11,967,900 | NEW | ||
| KROS | KEROS THERAPEUTICS INC | 12.65 | 1,435,950 | 95,059,900 | ADDED | 35.41 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MRK | MERCK & CO INC | 1.40 | 79,600 | 10,503,200 | NEW | ||
| NUVL | NUVALENT INC | 14.37 | 1,436,960 | 107,902,000 | ADDED | 2,390 | |
| PCVX | VAXCYTE INC | 25.02 | 2,750,800 | 187,907,000 | ADDED | 374 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TGTX | TG THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| XNCR | XENCOR INC | 3.27 | 1,109,650 | 24,556,600 | NEW | ||
| BIOHAVEN LTD | 10.75 | 1,476,970 | 80,775,700 | NEW | |||
| APOGEE THERAPEUTICS INC | 7.36 | 832,198 | 55,299,600 | NEW | |||
| TOURMALINE BIO INC | 1.42 | 465,000 | 10,648,500 | NEW |